Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -68 | -36 | -329 | -273 | -225 |
| Other Working Capital | -30 | -27 | -394 | 715 | 700 |
| Other Operating Activity | 0 | 0 | -66 | 94 | 94 |
| Operating Cash Flow | $-98 | $-62 | $-789 | $536 | $570 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,217 | N/A | N/A |
| PPE Investments | 0 | 0 | N/A | -79 | -79 |
| Other Investing Activity | 19 | 9 | 97 | 85 | 65 |
| Investing Cash Flow | $19 | $9 | $1,314 | $6 | $-14 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 917 | 916 | 391 | 391 | 391 |
| End Cash Position | 838 | 863 | 916 | 933 | 946 |
| Net Cash Flow | $-79 | $-53 | $525 | $542 | $556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98 | -62 | -789 | 536 | 570 |
| Free Cash Flow | -98 | -62 | -789 | 536 | 570 |